Dr. Khalid Tabbara, Vice President at the University, praised KFH-B for their commitment in supporting initiatives like this in the health sector. He stressed that the Symposium is the first of its kind in the region because it addresses issues related to diabetes that have not been addressed before, such as stem cell transplant, treatment of difficult cases, containing the disease complications as well as the latest treatments in the global drug markets.
The Endocrinology, diabetes and fats Consultant at the University Medical Center in King Abdullah Medical City, Dr. Nasreen Al Sayed thanked KFH-Bahrain for their contribution towards the Symposium which will be attended by nearly 200 doctors specialized in diabetes, family medication, esoteric and dietician from the GCC. The Symposium aims at raising the awareness of diabetes and reviewing the scientific developments in the field of diagnostics. It will also stress the importance of understanding the nature of the disease and ways to control it through education and getting acquainted with how to live with it. Diabetes is considered to be one of the most fatal and chronic diseases nowadays that affects many men, women and children.
“The Bank is a supporter of such important medical initiatives as it recognizes the importance of specialized medical conferences, forums and symposiums hosted by universities of higher education like the Arabian Gulf University. We are dedicated to promoting events that discuss key medical issues and diseases in the region, in particular diabetes which is spreading globally,” Abdulhakeem Alkhayyat, Managing Director and CEO of Kuwait Finance House-B, said.
“We are pleased to partner with the Arabian Gulf University that has more than 30 years experience in higher medical education”.
The First International Symposium will include workshops to train the participants on diagnosing the complications of diabetes and treatment of the difficult and chronic cases, as well as reviewing the latest global recommendations. Research papers that will be presented will include a wide range of latest topics in the treatment of diabetes and endocrine while focusing on topics of interest to specialists in the treatment of these diseases in both children and adults.